Canada· CA-DIN-02229452
MEFENAMIC
A mefenamic acid product containing mefenamic acid, registered in Canada by AA PHARMA INC. The same ATC class is registered in 7 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Mefenamic acid is registered in 7 of 19 countries.
Countries holding a registration under ATC M01AG01 (mefenamic acid), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 3 of them publish a price we can compare per daily dose
Mefenamic acid · ATC M01AG01
7 / 19 countries
- Canada
- Finlandprice
- Ireland
- Japan
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mefenamic acid costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mefenamic acid · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.48
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- MEFENAMIC ACID
- Manufacturer
- AA PHARMA INC
- Country
- Canada (CA)
- ATC code
- M01AG01
- ATC class
- Mefenamic acid
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for mefenamic acid.
Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mefenamic acid · interactions on record
335 records
- 57 severe
- 156 moderate
- 16 minor
- 24 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
82 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mefenamic acid in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDysman 250 capsulesAshbourne Pharmaceuticals Ltd
- United StatesMefenamic acidMicro Labs Limited
- IrelandMEFAC 250 mg hard capsulesRowa Pharmaceuticals Limited,
- SwitzerlandPonstan, HartkapselnPfizer AG
- FrancePONSTYL 250 mg, gélulePFIZER HOLDING FRANCE
- SpainCOSLAN 250 MG CAPSULAS DURASPfizer S.L.
- FinlandPonstanWarner Lambert Nordic AB
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Mefenam, Parkakut
- Cyprus · Aidol, Alfoxan
- Spain · Coslan
- France · Ponstyl
- United Kingdom (Northern Ireland) · Contraflam, Mefenamic Acid
- Greece · Acinic, Aidol
- Hungary · Ponmel
- Ireland · Mefac, Ponstan
- Malta · Alfoxan, Mefac
- Romania · Vidan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcdbc9d4-b73b-4a95-9a82-5e356f215575 GET /v1/drugs/bcdbc9d4-b73b-4a95-9a82-5e356f215575?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02229452",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "M01AG01",
"schedule": [
"Prescription"
],
"drug_code": "47338",
"strengths": [
"250 MG"
],
"ahfs_class": null,
"substances": [
"MEFENAMIC ACID"
],
"product_categorization": null
}See everything about mefenamic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.